Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Hospital Pharmacy|August 12, 2021
High-Dose Daptomycin Is Well Tolerated via 2-Minute IV Push AdministrationChristian M Gill, Rachel M Kenney, Charles T Makowski, et al.
Infectious Diseases and Therapy|March 8, 2017
The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream InfectionsLauren K Flynt, Rachel M Kenney, Marcus J Zervos, et al.
Expert Opinion on Pharmacotherapy|June 8, 2018
Combatting resistant enterococcal infections: a pharmacotherapy reviewNicholas J Mercuro, Susan L Davis, Marcus J Zervos, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 23, 2010
Nontraditional pharmacy residency at a large teaching hospitalMegan L Winegardner, Susan L Davis, Edward G Szandzik, et al.
Infectious Diseases and Therapy|April 2, 2018
Delafloxacin: Place in Therapy and Review of Microbiologic, Clinical and Pharmacologic PropertiesSarah C J Jorgensen, Nicholas J Mercuro, Susan L Davis, et al.
Infection Control and Hospital Epidemiology|September 29, 2021
Outcomes of clinical decision support for outpatient management of Clostridioides difficile infectionTiffany Wu, Susan L Davis, Brian Church, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 27, 2024
Outcomes of adjunctive eravacycline for severe and fulminant Clostridioides difficile infectionChristen J Arena, Rachel M Kenney, Mayur Ramesh, et al.
The Annals of Pharmacotherapy|November 14, 2016
Randomized Controlled Trial to Determine the Efficacy of Early Switch From Vancomycin to Vancomycin Alternatives as a Strategy to Prevent Nephrotoxicity in Patients With Multiple Risk Factors for Adverse Renal Outcomes (STOP-NT)Joseph J Carreno, Rachel M Kenney, George Divine, et al.
Infection Control and Hospital Epidemiology|September 29, 2006
Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureusSusan L Davis, Michael J Rybak, Muhammad Amjad, et al.
Pharmacotherapy|March 7, 2012
Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohortRavina Kullar, Susan L Davis, Thomas N Taylor, et al.
Pageof 10